News: Indonesia

Indonesia's potential wealth in natural resources, as the second-largest country in terms of biodiversity, boasting over 28 thousand species of plants and 2,848 medicinal plants, presents significant opportunities for the development of natural medicine and Indonesia Indigenous Modern Medicine (OMAI) phytopharmaceuticals. Dra. Reri Indriani, Senior Expert Pharmacist and Food Supervisor…

Dexa Group is a research-based pharmaceutical company committed to actively participating in developing phytopharmaca. This commitment aligns with the government's efforts to address the dependency on imported raw materials for medicines by utilizing the country's natural resources to produce phytopharmaca. "The government provides full support for developing medicines, including natural…

Stimuno has once again secured the Top Brand For Kids Award, marking its 14th accolade in recognition of its unwavering commitment to quality and adherence to halal production standards from beginning to end, ensuring its consumers' comfort and safety. Marketing Magazine and Frontier Group have bestowed the Top Brand For…

Clinical and Molecular Pharmacologist Prof. Raymond Tjandrawinata of Dexa Group and Unika Atma Jaya, who also pioneers the development of Indonesia Indigenous Modern Medicine (OMAI), has achieved third place among the top pharmaceutical scientists in Indonesia. The AD Scientific Index provided this ranking based on a system that analyzes scientific…

To encourage sustainable environment and implement Environmental, Social, and Governance (ESG) principles, Dexa Group supports research facilities at Rumah Perubahan by providing microscopes. The microscopes were presented by Dexa Group's Business Development and Scientific Affairs Director, Prof. Raymond Tjandrawinata, to the Founder of Rumah Perubahan, Prof. Rhenald Kasali on Friday,…

Successfully implementing public relations programs that create positive impact to society and company, Corporate Communications Dexa Group has won three awards at the Public Relations Indonesia Awards (PRIA) which took place on Thursday, March 7 2024 in Denpasar, Bali. Dexa Group's Corporate Communications won awards in the PR Program category…

More Than 20 Years Trusted by Indonesian Families, STIMUNO Wins the 2024 Indonesia Healthcare Award Corporate News - STIMUNO, as the first phytopharmaceutical immunomodulator in Indonesia, clinically proven, halal certified, of high quality, and safe, has continued to be trusted by Indonesian families for over 20 years. In recognition of…

Dexa Group has achieved the esteemed Indonesia Public Relations Awards (IPRA) 2024 in the category of Best Public Relations in the Pharmaceutical Industry from Warta Ekonomi. This recognition acknowledges Dexa Group's adept execution of a strategic role in public relations amid the challenges and uncertainties of business dynamics. Notably, this…

To accelerate the independence of the national pharmaceutical and medical devices sector, the Dexa Group has taken a proactive step by constructing its inaugural medical device industrial facility via PT Deca Metric Medica. This facility will allow Indonesia to produce medical device products, including wound dressings, which have emerged as…

The Indonesian government's health transformation pillar includes health technology transformation. Amid rapid advancements in the health sector, innovation must be sought to provide solutions and extend health services to the larger community. As a result, through the Dexa Group Hackathon for Talent Catch 2023, Dexa Group helps encourage the nation's…